Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H2, 2016

GlobalData
63 Pages - GLDATA57870
$2,500.00

Summary

GlobalData's clinical trial report, “Herpes Labialis (Oral Herpes) Global Clinical Trials Review, H2, 2016" provides an overview of Herpes Labialis (Oral Herpes) clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Labialis (Oral Herpes). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned

Radiant Research Inc
GlaxoSmithKline Plc
Medivir AB
NanoBio Corp
Novartis AG
Mylan NV
HoneyLab Ltd
Harras Pharma Curarina GmbH
Engelhard Arzneimittel GmbH & Co KG
DermResearch Inc

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials 26
Prominent Drugs 27
Latest Clinical Trials News on Herpes Labialis (Oral Herpes) 28
Dec 01, 2016: AiCuris Announces Start of LipP 1: First Subject Enrolled in the Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes 28
Clinical Trial Profile Snapshots 29
Appendix 60
Abbreviations 60
Definitions 60
Research Methodology 61
Secondary Research 61
About GlobalData 62
Contact Us 62
Disclaimer 62
Source 63

List of Tables
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13
Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
Herpes Labialis (Oral Herpes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Phase, 2016* 19
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Herpes Labialis (Oral Herpes) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

List of Figures
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12
Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
Herpes Labialis (Oral Herpes) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
Proportion of Herpes Labialis (Oral Herpes) to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
Herpes Labialis (Oral Herpes) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
Herpes Labialis (Oral Herpes) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
Herpes Labialis (Oral Herpes) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
Herpes Labialis (Oral Herpes) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27
GlobalData Methodology 61

$2,500.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports